Home/Filings/4/0001424422-16-000039
4//SEC Filing

BioPharmX Corp 4

Accession 0001424422-16-000039

CIK 0001504167operating

Filed

Dec 11, 7:00 PM ET

Accepted

Dec 12, 5:37 PM ET

Size

5.6 KB

Accession

0001424422-16-000039

Insider Transaction Report

Form 4
Period: 2016-12-08
Transactions
  • Award

    Option to purchase common stock

    2016-12-08$0.42/sh+150,000$63,000150,000 total(indirect: By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03)
    Exercise: $0.42From: 2017-01-08Exp: 2026-12-08Common stock (150,000 underlying)
Footnotes (2)
  • [F1]This option vests ratably over 12 months with the first vesting starting on 1/8/17.
  • [F2]Mr. Morlock is a co-trustee and co-beneficiary of the Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03

Issuer

BioPharmX Corp

CIK 0001504167

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001504167

Filing Metadata

Form type
4
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 5:37 PM ET
Size
5.6 KB